Cincinnati Children's Hospital Medical Center Logo

Infectious Diseases

Loading...

Grants, Contracts, and Industry Agreements

Grant and Contract Awards Annual Direct / Project Period Direct

BERNSTEIN, D

Phase III Vaccine Trial in Sero-Negative Women
N01 AI 04525011/01/02 - 08/31/09 $4,716 / $1,380,600
Animal Models of Human Viral Infections for Evaluation
N01 AI 01543805/01/01 - 04/30/10 $183,333 / $2,179,143
The Natural History of CMV-Related Hearing Loss
HHSN26020050008C06/01/05 - 05/31/12 $202,780 / $1,079,552
Vaccine and Treatment Evaluation Units
HHSN272200800006C11/01/07 - 10/31/14 $3,379,995 / $16,899,332

FARKAS, T

Enteric Viral Infections of Captive Rhesus Macaques
R21 RR 00248704/01/08 - 03/31/10 $35,911 / $75,773

JIANG, X

Norway-Like Viruses and Their Receptors
R01 AI 05564908/01/05 - 01/31/10 $209,287 / $1,012,500
Novel Broad Spectrum Therapeutic Glycans Against Cancer
U01 AI 07556309/01/07 - 08/31/13 $12,249 / $256,076

SAWTELL, N

Ocular HSV Infection Latency and Pathogenesis
R01 EY 01316805/01/08 - 04/30/12 $98,000 / $392,000
Neuronal Regulation of HSV Lytic and Latent Infection
R21 AI 08108312/01/08 - 11/30/10 $150,000 / $275,000
Forward "Systems Genetics" Approach to Identify Host Genes and Pathways that Moderate HSV Pathogenesis
07/01/08 - 12/31/09 $25,000 / $25,000

STAAT, M

Enhanced Surveillance for Newly Vaccine Preventable Diseases
U01 IP 00014708/31/07 - 08/30/09 $636,530 / $1,074,546

WARD, R

PATH sub GAT.1334-07574
11/15/07 - 12/31/09 $44,358 / $143,529
Current Year Direct$4,982,159
Industry Contracts

Bernstein, D

$ 15,370
$ 100,967
$ 97,861

Brady, R

$ 72,583

Cardin

$ 54,518

Frenck, R

$ 2,156
$ 260,280

Gerber

$ 30,960
$ 122,255

Jiang

$ 2,310
$ 53,116

McNeal

$ 41,156

Staat, M

$ 539,000
$ 123,200
$ 123,160

Subbramanian

$ 27,268

Ward

$ 853,433
$ 160,845
$ 78,475
$ 367,545
Current Year Direct Receipts$ 3,126,458
Funded Collaborative Efforts

BERNSTEIN, D

Behavioral and Virologic Impact of HPV Immunization
Kahn, J01/15/08 - 01/14/135 %
A Randomized, Double-Blind, Placebo-Contolled Dose Esculation,Inpatient Phase I Study to Determine the Safety and Immunogenicity of a Single Oral Dose of a Combined Enterotoxigenic Escherichia coli (ETEC)-Cholera Vaccine (Peru-15-pCTB) in Healthy Adult Subjects
Cohen, M05/01/08 - 11/30/105 %

Jiang, X

Novel Genetic and Salivary Glycan Biomarkers for Risk of NEC in ELBW Infants
Morrow, A01/15/09 - 12/31/1310 %
Total$ 8,108,167